Concepedia

Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer

Taylor Orellana, H. Kim, Sushil Beriwal, Rohit Bhargava, J. Berger, Ronald J. Buckanovich, Lan Coffman, Madeleine Courtney‐Brooks, Alexander Olawaiye, Paniti Sukumvanich,

Gynecologic Oncology · 2021 · 30 citations · 33 references

Concepts

MedicineOncologyPharmacoeconomicsCost-effectiveness AnalysisGynecologic OncologyMolecular OncologyCancer Early DetectionEarly Cancer DetectionEndometrial CancerMolecular Classification Of TumorsMolecular Tumor ProfilingTumor ClassificationCost-effectivenessCost-effectiveness Analysis PerspectiveEndometrial Cancer Risk StratificationEndometrial Tumor ClassificationIntegrated Molecular ClassificationMolecular Tumor ClassificationTumor Classification Systems

References

33

Cancer statistics, 2020

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2020 · 21.4K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Integrated genomic characterization of endometrial carcinoma

Nature · 2013 · 5.8K citations · Full text

Medicine, Genetics, Oncology +17

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses

Gillian D Sanders, Peter J. Neumann, Anirban Basu et al. · JAMA · 2016 · 3K citations · Full text

Pharmacy, Health Administration, Health Policy +17

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

Peter J. Neumann, Joshua T. Cohen, Milton C. Weinstein · New England Journal of Medicine · 2014 · 2.3K citations

Pharmacy, Health Policy, Pharmacoeconomics +17

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Nicole Concin, Xavier Matías‐Guiu, Ignace Vergote et al. · International Journal of Gynecological Cancer · 2020 · 1.9K citations · Full text

Medicine, Gynecology, Oncology +13